Ultragenyx Pharmaceutical Inc. (0LIF)
LSE • 0LIF • US90400D1081
17.50Last close
Market Closed
LSE • 0LIF • US90400D1081
Ultragenyx Pharmaceutical Inc. (LSE: 0LIF) has a market capitalization of $1.69B. Last close $17.50 (as of 2026-11-05); 52-week range $12.87 to $41.50. ORTEX data as of 2026-11-03: short interest is 3.38% of free float, 366.5 days to cover and the average cost to borrow is 0.42%.